Skip to main content
. 2023 Feb 15;29(11):1723–1729. doi: 10.1093/ibd/izad016

Figure 3.

Figure 3.

Percentage of patients reporting ≥5-point increase (meaningful within-person change [MWPC]) in Functional Assessment of Chronic Illness Therapy–Fatigue score at induction and at maintenance among induction responders. ***P < .001 for upadacitinib (UPA) vs placebo (PBO). Maintenance results are based on induction responders. Nonresponder imputation incorporating multiple imputation to handle missing data due to coronavirus disease 2019. CI, confidence interval.